Methylphenidate for Borderline Personality Disorder in Adolescents
Phase 2
- Conditions
- Borderline Personality Disorder (BPD)Mental Health - Psychosis and personality disorders
- Registration Number
- ACTRN12609001013257
- Lead Sponsor
- Concord Hospital, Department of Psychiatry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Adolescent females with a diagnosis of Borderline Personality Disorder
Exclusion Criteria
- Comorbid diagnosis of Autistic Spectrum Disorder, clinically evident mental retardation or a tick disorder.
- Comorbid diagnosis of a significant medical disorder, such as active hepatic or renal disease, dementia, serious head injury or active cancer.
- Marked previous or current anxiety or psychotic symptoms.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical Global Impression Scale-Severity (CGI-S), measuring symptom severity and degree of interpersonal functioning.[Before treatment, at the end of 12-week treatment trial, and after a further 12 weeks.]
- Secondary Outcome Measures
Name Time Method il[Nil]